Earnings NewsHealthcareCatalyst Biosciences EPS misses by $0.14, beats on revenueNov. 12, 2021 8:46 AM ETCatalyst Biosciences, Inc. (CBIO) StockBy: Pranav Ghumatkar, SA News Editor Catalyst Biosciences (NASDAQ:CBIO): Q3 GAAP EPS of -$0.80 misses by $0.14. Revenue of $2.3M (+158.4% Y/Y) beats by $1.8M. Shares -31.63% PM. Press Release Cash, cash equivalents and, investments, as of September 30, 2021 were $64.5 million. Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgCBIO--Catalyst Biosciences, Inc.Trending AnalysisTrending News